PARSIPPANY, N.J.--(BUSINESS WIRE)--May 7, 2015--
Pacira
Pharmaceuticals, Inc. (NASDAQ: PCRX) today announced that Dave
Stack, president, chief executive officer and chairman of Pacira
Pharmaceuticals, is scheduled to present at the Bank of America Merrill
Lynch 2015 Health Care Conference at 8:40 a.m. PT on Thursday, May 14,
2015, in Las Vegas. Mr. Stack is expected to present an overview of the
company.
A live audio webcast of the Pacira presentation can be accessed by
visiting the “Investors & Media” section of the company’s website at investor.pacira.com.
A replay of the webcast will be archived on the Pacira website for two
weeks following the presentation date.
About Pacira
Pacira Pharmaceuticals, Inc. (NASDAQ: PCRX) is a specialty
pharmaceutical company focused on the clinical and commercial
development of new products that meet the needs of acute care
practitioners and their patients. The company’s flagship product,
EXPAREL® (bupivacaine liposome injectable suspension), indicated for
single-dose infiltration into the surgical site to produce postsurgical
analgesia, was commercially launched in the United States in April 2012.
EXPAREL and two other products have successfully utilized DepoFoam®, a
unique and proprietary product delivery technology that encapsulates
drugs without altering their molecular structure, and releases them over
a desired period of time. Additional information about Pacira is
available at www.pacira.com.
Source: Pacira Pharmaceuticals, Inc.
Investor Contact:
Pacira Pharmaceuticals, Inc.
Jessica
Cho, 973-254-3574
